The National Institute for Health and Care Excellence (NICE) faced "difficult decisions" when it deemed a breast cancer drug which can extend sufferers lives by "up to six months" was too expensive, according to a health expert.
Dr Hilary Jones told Daybreak the £90,000 price tag per patient would have meant taking funds away from other vital services the NHS provides.
More top news
Ed Miliband would rather discuss working families and the NHS, but the question of English 'home rule' looms large over Labour's conference.
A British scientist says the age women may be able to conceive children could soon be significantly extended.
Simon Cowell admitted he was "so embarrassed" after his shirt burst open during an X Factor audition.